A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Neurosciences Bookmark and Share

Neurosciences

Study of the nervous system has a long tradition at City of Hope, which was one of the first institutions in North America to establish a neurobiology research department.

The Department of Neurosciences offers a multidisciplinary research and training environment in neurobiology, with a particular focus on developmental aspects of the nervous system. Research in the department encompasses molecular and cellular neurobiology, genetics and neurophysiology, with ongoing studies in neurogenesis and synaptogenesis, migration and specification, degeneration and embryonic stem cell differentiation.

Researchers in the department collaborate with colleagues in other basic science departments and divisions as well as clinical researchers in neuro-oncology programs, focusing on cancer immunotherapy and neurosurgery.
 
Laboratory Research
The Department of Neurosciences spans a broad range of research interests; grouped into three major categories:

I.Several investigators are interested in the earliest periods of neurogenesis and lineage commitment, and are examining stem and progenitor cells in developing and mature brain:
 
  • Qiang Lu, Ph.D. – Neural Progenitor/Stem Cells in Brain Development
    Dr. Lu’s research is concerned with intercellular signaling by ephrins and Eph receptors and their regulation of neuronal birth and migration during early development of the cerebral cortex.
 
  • Yanhong Shi, Ph.D. – Nuclear Receptors in Neural Stem Cells and Adult Neurogenesis
    Dr. Shi is studying the nuclear receptors that control generation and differentiation of neural lineage stem cells in the adult nervous system.
 
  • Michael Barish, Ph.D. – Neurobiology of Development
    Dr. Barish is investigating early electrical activity in the developing hippocampus and cortex and its relationship to neural birth, migration and maturation.
     
  • Karen S. Aboody, M.D.Translational Research
    Dr. Aboody oversees a translational research laboratory focused on neural stem cells (NSCs) as a platform for targeted delivery of therapeutic agents to invasive and metastatic solid tumors.

II.Several faculty have research foci in neural specification, processes that impart individuality to developing neurons, and in the functioning of mature neurons.
 
  • Paul Salvaterra, Ph.D. – Molecular Neurobiology
    Dr. Salvaterra’s research is focused on the regulation of transmitter phenotype, how gene expression is coordinated to allow synthesis and release of individual neurotransmitters.
 
  • Toshifumi Tomoda, Ph.D. – Axonal Trafficking / Neurodegeneration
    Dr. Tomoda is interested in membrane transport and cycling, and its role in axon and dendrite growth, differentiation of synapses, and stress-induced autophagy.
 
  • Kazuo Ikeda, Ph.D. – Neurophysiology
    Dr. Ikeda studies the mechanisms of synaptic transmission and plasticity, focusing on endocytosis of synaptic vesicle membrane from presynaptic terminals and processes of recovery from vesicle depletion as a consequence of activity.

III.Several faculty members also have projects that relate their fundamental research interests to mechanisms underlying diseases of the human nervous system.
 
  • Dr. Salvaterra is developing Drosophila models for Alzheimer’s and other degenerative diseases.
     
  • Dr. Lu is examining how alteration in the neural stem cell decision to proliferate or differentiate controlled by ephrin/Eph receptor signaling may be involved in the earliest stages of tumorigenesis.
     
  • Dr. Tomoda is investigating possible connections between genes involved in membrane cycling and autophagy, and several diseases including Huntington’s and schizophrenia.
     
  • Dr. Barish, in collaboration with Karen Aboody, M.D. , (Hematology/HCT) and Carlotta Glackin, Ph.D. , is examining the molecular mechanisms of neural progenitor cell migration to glioma and tumors outside the brain, and targeting of these tumors with genetically-modified therapeutics using immortalized neural progenitor cells.
     
  • Dr. Glackin and her laboratory are investigating the molecular mechanisms of a bHLH transcription factor, TWIST, in regulating cellular invasiveness. Understanding these mechanisms has allowed her laboratory to develop novel genetically-modified therapeutics that interferes with TWIST function to competitively inhibit cellular invasion of tumor cells.

Neurosciences Faculty

Neurosciences

Neurosciences

Study of the nervous system has a long tradition at City of Hope, which was one of the first institutions in North America to establish a neurobiology research department.

The Department of Neurosciences offers a multidisciplinary research and training environment in neurobiology, with a particular focus on developmental aspects of the nervous system. Research in the department encompasses molecular and cellular neurobiology, genetics and neurophysiology, with ongoing studies in neurogenesis and synaptogenesis, migration and specification, degeneration and embryonic stem cell differentiation.

Researchers in the department collaborate with colleagues in other basic science departments and divisions as well as clinical researchers in neuro-oncology programs, focusing on cancer immunotherapy and neurosurgery.
 
Laboratory Research
The Department of Neurosciences spans a broad range of research interests; grouped into three major categories:

I.Several investigators are interested in the earliest periods of neurogenesis and lineage commitment, and are examining stem and progenitor cells in developing and mature brain:
 
  • Qiang Lu, Ph.D. – Neural Progenitor/Stem Cells in Brain Development
    Dr. Lu’s research is concerned with intercellular signaling by ephrins and Eph receptors and their regulation of neuronal birth and migration during early development of the cerebral cortex.
 
  • Yanhong Shi, Ph.D. – Nuclear Receptors in Neural Stem Cells and Adult Neurogenesis
    Dr. Shi is studying the nuclear receptors that control generation and differentiation of neural lineage stem cells in the adult nervous system.
 
  • Michael Barish, Ph.D. – Neurobiology of Development
    Dr. Barish is investigating early electrical activity in the developing hippocampus and cortex and its relationship to neural birth, migration and maturation.
     
  • Karen S. Aboody, M.D.Translational Research
    Dr. Aboody oversees a translational research laboratory focused on neural stem cells (NSCs) as a platform for targeted delivery of therapeutic agents to invasive and metastatic solid tumors.

II.Several faculty have research foci in neural specification, processes that impart individuality to developing neurons, and in the functioning of mature neurons.
 
  • Paul Salvaterra, Ph.D. – Molecular Neurobiology
    Dr. Salvaterra’s research is focused on the regulation of transmitter phenotype, how gene expression is coordinated to allow synthesis and release of individual neurotransmitters.
 
  • Toshifumi Tomoda, Ph.D. – Axonal Trafficking / Neurodegeneration
    Dr. Tomoda is interested in membrane transport and cycling, and its role in axon and dendrite growth, differentiation of synapses, and stress-induced autophagy.
 
  • Kazuo Ikeda, Ph.D. – Neurophysiology
    Dr. Ikeda studies the mechanisms of synaptic transmission and plasticity, focusing on endocytosis of synaptic vesicle membrane from presynaptic terminals and processes of recovery from vesicle depletion as a consequence of activity.

III.Several faculty members also have projects that relate their fundamental research interests to mechanisms underlying diseases of the human nervous system.
 
  • Dr. Salvaterra is developing Drosophila models for Alzheimer’s and other degenerative diseases.
     
  • Dr. Lu is examining how alteration in the neural stem cell decision to proliferate or differentiate controlled by ephrin/Eph receptor signaling may be involved in the earliest stages of tumorigenesis.
     
  • Dr. Tomoda is investigating possible connections between genes involved in membrane cycling and autophagy, and several diseases including Huntington’s and schizophrenia.
     
  • Dr. Barish, in collaboration with Karen Aboody, M.D. , (Hematology/HCT) and Carlotta Glackin, Ph.D. , is examining the molecular mechanisms of neural progenitor cell migration to glioma and tumors outside the brain, and targeting of these tumors with genetically-modified therapeutics using immortalized neural progenitor cells.
     
  • Dr. Glackin and her laboratory are investigating the molecular mechanisms of a bHLH transcription factor, TWIST, in regulating cellular invasiveness. Understanding these mechanisms has allowed her laboratory to develop novel genetically-modified therapeutics that interferes with TWIST function to competitively inhibit cellular invasion of tumor cells.

Neurosciences Faculty

Neurosciences Faculty

Overview
Beckman Research Institute of City of Hope is responsible for fundamentally expanding the world’s understanding of how biology affects diseases such as cancer, HIV/AIDS and diabetes.
 
 
Research Departments/Divisions

City of Hope is a leader in translational research - integrating basic science, clinical research and patient care.
 

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

City of Hope’s Irell & Manella Graduate School of Biological Sciences equips students with the skills and strategies to transform the future of modern medicine.
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 


NEWS & UPDATES
  • The outlook and length of survival has not changed much in the past 25 years for patients suffering from an aggressive form of pancreatic cancer known as pancreatic ductal adenocarcinoma (PDAC). These patients still have few options for therapy; currently available therapies are generally toxic and do not incre...
  • “With bladder cancer, the majority of patients that I see can be cured,” said urologist Kevin Chan, M.D., head of reconstructive urology at City of Hope. “The challenge is to get patients the same quality of life that they had before surgery.” To meet this challenge, Chan and the urologic team at City of Hope [...
  • Already pioneers in the use of immunotherapy, City of Hope researchers are now testing the bold approach to cancer treatment against one of medicine’s biggest challenges: brain cancer. This month, they will launch a clinical trial using patients’ own modified T cells to fight advanced brain tumors. One of but a...
  • Brain cancer may be one of the most-frightening diagnoses people can receive, striking at the very center of who we are as individuals. Further, it often develops over time, causing no symptoms until it’s already advanced. Listen to City of Hope Radio as Behnam Badie, M.D., director of the Brain Tumor Pro...
  • The whole is greater than the sum of its parts. It takes a village. No man is an island. Choose your aphorism: It’s a simple truth that collaboration usually is better than isolation. That’s especially true when you’re trying to introduce healthful habits and deliver health care to people at risk of disease and...
  • When Maryland Governor Larry Hogan announced earlier this week that he has the most common form of non-Hodgkin lymphoma, he was giving voice to the experience of more than 71,000 Americans each year. The announcement came with Hogan’s promise to stay in office while undergoing aggressive treatment for the...
  • The spine can be affected by many different kinds of tumors. Malignant, or cancerous, tumors can arise within the spine itself. Secondary spinal tumors, which are actually much more common, begin as cancers in another part of the body, such as the breast and prostate, and then spread, or metastasize, to the spi...
  • Although most cancer occurs in older adults, the bulk of cancer research doesn’t focus on this vulnerable and fast-growing population. City of Hope and its Cancer and Aging Research Team aim to change that, and they’re getting a significant boost from Professional Practice Leader Peggy Burhenn, R.N....
  • Liz Graef-Larcher’s first brain tumor was discovered by accident six years ago. The then-48-year-old with a long history of sinus problems and headaches had been sent for an MRI, and the scan found a lesion in her brain called a meningioma – a tumor that arises in the meninges, the layers of tissue that cover a...
  • The colon and rectum are parts of the body’s gastrointestinal system, also called the digestive tract. After food is digested in the stomach and nutrients are absorbed in the small intestine, the remaining material moves down into the lower large intestine (colon) where water and nutrients are absorbed. The low...
  • If there is one truism about hospital stays it is that patients want to get out. For many, however, the joy of being discharged is tempered by the unexpected challenges that recovery in a new setting may pose. Even with professional help, the quality of care and treatment that patients receive at City of Hope [...
  • Jana Portnow, M.D., associate director of the Brain Tumor Program at City of Hope, didn’t expect to specialize in treating brain tumors. But, early in her career, she undertook a year of research on pain management and palliative care and, in that program, got to know many patients with brain tumors. After that...
  • Ask any patient: Nurses are as pivotal in their care as doctors. They answer the call of a patient in the middle of the night, they hold the patient’s hand as he or she takes on yet another round of treatment and, in the best-case scenario, they wave goodbye as the patient leaves the hospital, […]
  • Many oncologists, not to mention their patients, might think that there’s no place for mathematical analysis in the treatment of cancer. They might think that all treatment decisions are based on unique factors affecting individual patients, with no connection to other patients and their treatment regimen...
  • Within three days in 2007, Stephanie Hosford, then 37, learned that she was pregnant with her long-awaited second child – and that she had triple-negative breast cancer. Soon afterward, Hosford discovered that she and her husband, Grant, had been approved to adopt a little girl from China.  After encountering m...